Generalized peroxisome-deficient disorders including cerebro-hepato-renal Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease are autosomal recessive diseases, where catalase-containing particles (peroxisomes) are morphologically absent. We previously isolated two Chinese hamster ovary (CHO) cell mutants (Z24 and Z65) that resemble the fibroblasts from patients with such diseases, in their defective peroxisome assembly (Tsukamoto, T., S. Yokota, and Y. Fujiki. 1990. J. Cell Biol. 110:651-660). Here we report isolation by the P9OH/UV method of a peroxisome-deficient CHO mutant, ZP92, of the third complementation group distinct from those of Z24 and Z65. Peroxisomal membrane ghosts were noted by immunochemical staining in all of the CHO mutants. Complementation analysis by cell fusion of the CHO mutants with cultured fibroblasts from patients with generalized peroxisomal disorders revealed that two CHO mutants (Z24 and ZP92) represent the human complementation groups, E (the same as group 1 in the U.S.) and C (the same as group 4), respectively. These CHO cell mutants are an apparently relevant animal cell model for studies on the molecular bases and primary defects of human peroxisome-deficient diseases. 
Introduction
Peroxisome is an ubiquitous intracellular organelle bounded by a unit membrane in eukaryotes, yeast to human, and functions in essential metabolic pathways including ,B-oxidation of very long chain fatty acids and synthesis of etherglycerolipids, such as plasmalogen ( 1, 2) . Human peroxisome-deficient disPlease address correspondence to Dr. Yukio Fujiki, Meiji Institute of Health Science, Odawara 250, Japan. T. Tsukamoto's present address is Department of Life Science, Himeji Institute of Technology, Kamigori, Hyogo 678-12, Japan.
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1. Abbreviations used in this paper: AOx, acyl-CoA oxidase; CHO, Chinese hamster ovary; DHAP-ATase, dihydroxyacetonephosphate acyltransferase; IMP, peroxisomal integral membrane protein; PAF-l, peroxisome assembly factor-l; P12, 12-(1'-pyrene)dodecanoic acid; P9OH, 9-( l'-pyrene)nonanol; TGT, 6-thioguanine resistant; thiolase, 3-ketoacyl-CoA thiolase; ZS, Zellweger syndrome.
orders are autosomal recessive (2, 3) and include at least eight different genotypes thus far reported (4) (5) (6) , with three distinct phenotypes of diseases; i.e., cerebro-hepato-renal Zellweger syndrome (ZS),' neonatal adrenoleukodystrophy, and infantile Refsum disease ( 1-3). Goldfischer et al. (7) reported that no peroxisome was observed in electron microscopy ofthe liver and kidney from patients with Zellweger syndrome. Recent findings are consistent with the notion that these disorders are closely or tightly linked to the dysfunction of peroxisomes, which causes anomalies including accumulation of very long chain fatty acids in body fluid and very low level of plasmalogen in various tissues, such as the brain and erythrocytes (1) (2) (3) (10) and several mutant clones ofone complementation group ( 1 ). Zoeller et al. ( 11 ) noted by cell fusion analysis that genetic lesion oftheir mutants differed from those oftwo complementation groups of ZS patients. By means ofcDNA transfection followed by genetic complementation assay, we isolated a cDNA encoding peroxisome assembly factor-1 (PAF-1 ) that restores the assembly ofperoxisomes and complements the abnormalities in the CHO mutant Z65 (12) . Here, we report a CHO mutant ZP92 that is defective in peroxisome formation, phenotypically similar to but genotypically distinct from Z24 and Z65. By a complete set of complementation analyses among three CHO mutants and eight groups of fibroblasts from patients with generalized peroxisomal disorders such as ZS, two CHO mutants, Z24 and ZP92, were revealed to be respectively in the same complementation group of two genotypically separate ZS patients. These CHO mutants appear to be potent somatic cell models for human peroxisome-deficient disorders.
Methods
Selection ofperoxisome-deficient CHO (Fig. 2 B) . Punctate staining pattern was noted in the wild type cells, as seen with anticatalase antibody. Larger but fewer particles immunoreactive with anti-70 IMP antibody were de- tected in all of the mutants, similar to those "peroxisomal ghost"-like vesicles seen in the fibroblasts from Zellweger patients (8, 9) .
The CHO mutant ZP92 was defective in DHAP-ATase and sensitive to the P1 2/UV treatment (Table I) . After selection by the P9OH/UV method, 90% of ZP92 cells survived, but only < 0.001% of the wild type CHO cells were viable. All findings were also evident in the mutants Z24 and Z65.
Biogenesis of peroxisomal enzymes was investigated in the mutant ZP92 and its hybrids with Z24 and Z65, respectively, that had been labeled with [35S]methionine. Acyl-CoA oxidase (AOx), the first enzyme of peroxisomal #-oxidation system, is a hetero-dimer comprising 75-kD A, 53-kD B, and 22-kD C polypeptide components (10, 15) ; B and C are derived from A (16, 17) . All ofthree "5S-polypeptide components were evident in the wild type CHO cells (Fig. 3 , lane 5) with a faint band ofC attributed to the low content of methionine (10, 15) , whereas the reduced 75-kD 3S-A form ofAOx, but not converted forms (53-kD B and 22-kD C components) was detected in ZP92 because of a rapid degradation, as noted in the Z24 and Z65 (10) (Fig. 3, lane 6) . The third enzyme, 3-ketoacyl-CoA thiolase (thiolase), is synthesized as a larger precursor of 44-kD, then processed to a 41-kD mature form (10, 16, 18) . Only a 44-kD 35S-precursor ofthiolase was detectable in ZP92, consistent with the finding in Z24 and Z65 (10) , although the 41-kD mature protein was apparent in the wild type cells (Fig. 3, lanes  1 and 2) . In the hybrid cells ofZP92 with Z24 and Z65, respectively, appropriate processing ofAOx and thiolase was evident, as in the wild type (lanes 3, 4, 7, and 8, respectively). These results accordingly support a notion that a CHO mutant ZP92 belongs to a complementation group distinct from those ofZ24 and Z65.
Analysis ofcellfusion with fibroblasts from Zellweger patients. Next, we searched for by cell fusion and staining with anticatalase antibody, human fibroblasts from ZS patients that belong to the same complementation group as each of the CHO mutants. Numerous punctate catalase-containing structures, peroxisomes, were noted in the fibroblasts from a control, whereas catalase was stained in a diffused manner in the cytosol of the fibroblasts from patients with ZS and neonatal adrenoleukodystrophy who belonged to complementation groups B and C (the same as group 4 in the U.S.), and E (group 1 in the U.S.) (Fig. 4, a-d) . Cytosolic catalase was also noted in fibroblasts from ZS patients ofthe other groups, A, D, 2,3, and 6 (not shown). All combinations of cell fusion between three CHO mutants and fibroblasts were done and the hybrid cells were also stained for catalase (Table II) . All cell hybrids except two contained peroxisomes, suggesting that they are each in different complementation groups, as represented in Fig. 4 (eg, and i) 
(4).
We made use of a selection (not screening [10, 19] ) procedure ofMorand et al. ( 13 ) to further isolate CHO cell mutants defective in peroxisome biogenesis. We isolated eight independent, apparently P9OH/UV-resistant, and peroxisome-deficient mutant cell clones, in which seven were found to be in the same complementation group as Z65 (not shown). One mutant ZP92 was in the third group; no mutant belonging to the complementation group of Z24 was isolated in this study. Gene lesions in Z65-type mutant cells may occur with higher frequency than those in other types of CHO mutants, presumably all resulting in dysfunction of PAF-1. Very similar to Z24 and Z65, the mutant ZP92 was defective in assembly ofperoxisomes, albeit normal biosynthesis ofperoxisomal proteins. Fugroups C and E in Japan (American groups 4 and 1), respectively (Fig. 4, h and i) . The results strongly suggest that CHO mutants ZP92 and Z24 are in the same complementation groups as C (4) and E ( 1 ), respectively. It is ofinterest to note that nuclei in the fused cells appeared to be stained in a diffused manner, although the reason is unknown.
The results obtained by morphological method in complementation analysis were assessed by biochemical studies on the biogenesis ofAOx and thiolase. In the fused cells ofZP92 with ZS fibroblasts from group C, only the A component of AOx was noted, as seen in the unfused ZS fibroblasts from groups B and C (Fig. 5 A, lanes 2, 3, and 5 ). Proper proteolytic conversion ofAOx was apparent in the fibroblasts from a control and the hybrids such as that of Z65 cells with ZS fibroblasts of group B (lanes I and 4). In the hybrid cells of ZP92 and ZS fibroblasts of group C, thiolase was detected as a precursor in both Chinese hamster and human forms, as noted in ZP92 and fibroblasts of ZS patients (Fig. 5 B, lanes 2, 4, 5, and 7) . The thiolase precursor was also seen in the fused cells of Z24 with fibroblasts from a ZS patient ofgroup E (the same as group 1 ) (not shown). Processing of thiolase precursor was evident in the wild type CHO cells, human control fibroblasts, and the hybrids including that of Z65 with ZS fibroblasts of group B (lanes 1, 3, and 6 ). It is noteworthy that both a precursor and a processed form ofthiolase of CHO cells were apparently faster in migration in SDS-PAGE than their human counterparts.
Taken together, CHO cell mutants ZP92 and Z24 appear to belong to the same complementation groups as fibroblasts from patients with ZS ofcomplementation groups C and E (the same as group 4 and 1), respectively. 20 ,um. sion ofZP92 with Z24 and Z65, respectively, resulted in apparently normal appearance in number and size of peroxisomes and appropriate proteolytic, intraperoxisomal ( 16, 17) , processing of peroxisomal enzyme proteins, AOx and thiolase. These results imply that the genetic lesion in ZP92 differs from those of Z24 and Z65, while the phenotypes of these three mutants are very similar, including those such as deficiency in DHAP-ATase, sensitivity to P12/UV treatment, and P90H/ UV resistance, all presumably caused by the absence ofperoxisomes.
Large but fewer empty membranous vesicles, peroxisomal ghosts, are detectable in fibroblasts from ZS patients (8, 9) . We noted ghostlike structures in all of the three CHO mutants, as seen in CHO mutants of one complementation group (11) . The peroxisomal ghosts in Z65 may become competent, after expression ofPAF-1, in translocation ofnewly synthesized proteins to form normal peroxisomes ( 12 ) . It is likely that peroxisomal ghosts divide through cell division, based on the notion of constant appearance of such structures in peroxisome-deficient CHO mutants, as well as in the fibroblasts from ZS patients. Peroxisomal ghosts may be related to clinical manifestations, although they need to be further characterized in morphological and biochemical details.
A complete set of cell fusion analyses among three groups of CHO mutants and eight groups of fibroblasts from ZS patients led us to finding that two CHO mutants, Z24 and ZP92, are in the same complementation groups as human fibroblasts of groups E( 1 ) and C(4), respectively. Respective genetic lesion(s) are likely in the same allele each in these two complementation groups of mutants and ZS fibroblasts. Taken together, nine complementation groups are evident in CHO mutants and ZS fibroblasts reported here; at least nine genes or their products, one of which is PAF-1, are apparently required for assembly of peroxisomes. Gene transfection and genetic complementation analysis using these two CHO mutants, Z24 and ZP92, may lead to identification ofpathogenic genes in ZS ofgroups E( 1 ) and C(4), respectively, as proven to be useful in the case of cDNA cloning of PAF-I ( 12).
In the yeast Saccharomyces cerevisiae, two genes (pas-J and pas-3) essential for peroxisome biogenesis have been identified (20, 21) . The deduced amino acid sequences of pas-J and pas-3 are distinct from that of PAF-1 cDNA. Isolation of mammalian homologues of pas-J and -3 might be useful for investigation of the primary etiology of peroxisome-deficient disorders. Similar type ofgene cloning with somatic animal cell mutants has been successful for delineation of the primary defects in human diseases, where only clinical phenotypes are evident. For instance, a human gene was cloned for DNA excision repair in xeroderma pigmentosum of group C by genetic complementation assay using a CHO mutant (22) .
Very recently, a female infant was diagnosed with a case of typical ZS but could not be classified into any of the previous, eight complementation groups of peroxisome-deficient disorders. Fibroblasts from this patient appeared to be in the same complementation group as that of Z65; rat PAF-l restored the assembly of peroxisomes in the fibroblasts. The primary defect of Zellweger syndrome in this patient was a point mutation in PAF-1 gene that caused a premature termination of PAF-1 (23).
